Tuesday, December 2, 2008 - 11:39PM EST

General Interest Articles

21. Epigenetic combination therapy as a tumor-selective treatment approach for hepatocellular carcinoma.

Author
Venturelli S; Armeanu S; Pathil A; Hsieh CJ; Weiss TS; Vonthein R; Wehrmann M; Gregor M; Lauer UM; Bitzer M;
Institution
Department of Internal Medicine I, Medical University Clinic, Tubingen, Germany.
Journal
Cancer. 2007 May 15;109(10):2132-41.
Abstract URL
Click here to view abstract

22. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions.

Author
Lee SG; Hwang S; Jung JP; Lee YJ; Kim KH; Ahn CS;
Institution
Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Centre, University of Ulsan College of Medicine, Seoul 138-736, Korea. sglee2@amc.seoul.kr
Journal
Br J Surg. 2007 Mar;94(3):320-6.
Abstract URL
Click here to view abstract

23. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience.

Author
Sahani DV; Holalkere NS; Mueller PR; Zhu AX;
Institution
Department of Abdominal Imaging and Interventional Radiology, Massachusetts General Hospital, 55 Fruit St, White 270, Boston, MA 02114, USA. dsahani@partners.org
Journal
Radiology. 2007 Jun;243(3):736-43.
Abstract URL
Click here to view abstract

24. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.

Author
Pekow JR; Bhan AK; Zheng H; Chung RT;
Institution
Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Journal
Cancer. 2007 Jun 15;109(12):2490-6.
Abstract URL
Click here to view abstract

25. Anticarcinogenic impact of interferon on patients with chronic hepatitis C: a large-scale long-term study in a single center.

Author
Ikeda K; Arase Y; Saitoh S; Kobayashi M; Someya T; Hosaka T; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Kumada H;
Institution
Department of Gastroenterology, Toranomon Hospital, Toranomon 2-2-2, Minato-ku, Tokyo 105-8470, Japan. ikedakenji@tora.email.ne.jp
Journal
Intervirology. 2006;49(1-2):82-90.
Abstract URL
Click here to view abstract

26. In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by novel traditional Chinese medicine-platinum anti-cancer agents.

Author
To KK; Ho YP; Au-Yeung SC; To KK; Ho YP; Au-Yeung SC;
Institution
School of Pharmacy, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR.
Journal
Anticancer Drugs. 2005 Sep;16(8):825-35.
Abstract URL
Click here to view abstract

27. Management of hepatocellular carcinoma.

Author
Bruix J; Sherman M;
Institution
BCLC Group. Liver Unit. Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain. bruix@ub.edu
Journal
Hepatology. 2005 Nov;42(5):1208-36.

28. The impact of newer treatment modalities on survival in patients with hepatocellular carcinoma.

Author
Taura N; Hamasaki K; Nakao K; Ichikawa T; Nishimura D; Goto T; Fukuta M; Kawashimo H; Fujimoto M; Kusumoto K; Motoyoshi Y; Shibata H; Eguchi K;
Institution
First Department of Internal Medicine, Nagasaki University School of Medicine, Sakamoto, Nagasaki, Japan. ntaura-gi@umin.ac.jp
Journal
Clin Gastroenterol Hepatol. 2006 Sep;4(9):1177-83. Epub 2006 Aug 8.
Abstract URL
Click here to view abstract

29. Long-term follow-up of interferon monotherapy in 454 consecutive naive patients infected with hepatitis C virus: multi-course interferon therapy may reduce the risk of hepatocellular carcinoma and increase survival.

Author
Akuta, Norio; Suzuki, Fumitaka; Suzuki, Yoshiyuki; Sezaki, Hitomi; Hosaka, Tetsuya; Someya, Takashi; Kobayashi, Masahiro; Saitoh, Satoshi; Arase, Yasuji; Ikeda, Kenji; Kobayashi, Mariko; Kumada, Hiromitsu;
Institution
Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan. akuta-gi@umin.ac.jp
Journal
Scand J Gastroenterol 2005 Jun;40(6):688-96.
Abstract URL
Click here to view abstract

30. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.

Author
Maluccio, Mary; Covey, Anne M; Gandhi, Ripal; Gonen, Mithat; Getrajdman, George I; Brody, Lynn A; Fong, Yuman; Jarnagin, William; D'Angelica, Michael; Blumgart, Leslie; DeMatteo, Ronald; Brown, Karen T;
Institution
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Journal
J Vasc Interv Radiol 2005 Jul;16(7):955-61.
Abstract URL
Click here to view abstract
Pages: 1 2 3